Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Crohn's Disease (CD): later-stage trial registry
3 of 7 indexed Crohn's Disease (CD) trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Crohn's Disease (CD): 7 US clinical trials tracked, 3 recruiting.
Crohn's Disease (CD) is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of North Carolina, Chapel Hill, running 2 of these trials.
Enrollment posture brief
Registry condition crohns-disease-cd
OPEN 3 | RECR 43% | LATE 2 | EARLY 1 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)
Crohn's Disease (CD) lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Crohn's Disease (CD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Crohn's Disease (CD) is recruiting below its size-band peers.
3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Crohn's Disease (CD) research.
University of North Carolina, Chapel Hill accounts for 2 of 7 trials (28.6%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Crohn's Disease (CD) enrolment sits around 120 participants.
Median target enrolment is 120 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.
-
Crohn's Disease (CD) research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
University of North Carolina, Chapel Hill
NCT07237516
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Takeda
NCT04779320
Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)
University of North Carolina, Chapel Hill
NCT07337902
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)
AbbVie
NCT04524611
Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
Vanderbilt University Medical Center
NCT07123350
A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease
AbbVie
NCT02782663
Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D
University of California, San Francisco
NCT01877577
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Crohn's Disease (CD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Crohn's Disease (CD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Crohn's Disease (CD) page
7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Crohn's Disease (CD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of North Carolina, Chapel Hill sponsors the most Crohn's Disease (CD) trials on record, review their full trial history before evaluating a specific study. See University of North Carolina, Chapel Hill's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Crohn's Disease (CD) condition card totals 7 registered trials; most-linked intervention ABT-494; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.